<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported) August 15, 1996
-------------------------------
CENTOCOR, INC.
- --------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
Pennsylvania 0-11103 23-2117202
- --------------------------------------------------------------------------------
(State or other juris- (Commission file (IRS Employer
diction of incorporation) number) Identification No.)
200 Great Valley Parkway, Malvern, Pennsylvania 19355
- --------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (610) 651-6000
-----------------------------
Not applicable
- --------------------------------------------------------------------------------
(Former name or former address, if changed since last report)
<PAGE>
Item 5. Other Events.
------------
On August 15, 1996, the Registrant entered into an agreement (the
"Agreement") with Fujisawa Pharmaceutical Co., Ltd. ("Fujisawa"), appointing
Fujisawa as the exclusive distributor of the Registrant's antiplatelet
monoclonal antibody product, ReoPro(TM), in Japan. As compensation for its
appointment as exclusive distributor, Fujisawa shall make a nonrefundable $15
million payment to the Registrant, and may make future milestone payments
aggregating $12 million.
The Registrant and Fujisawa will co-develop ReoPro(TM) in Japan and
jointly file for Japanese product approval. Fujisawa shall bear all external
costs associated with the clinical development of ReoPro(TM) in Japan.
<PAGE>
SIGNATURES
----------
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
CENTOCOR, INC.
Registrant
Dated: August 16, 1996 By: /s/ George D. Hobbs
--------------------------------
George D. Hobbs, Vice President,
Corporate Counsel and
Secretary
